FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/30/2026

1. NTAP
2. SPY
3. NVDA
4. MDB
5. FFAI
6. MTN
7. META
8. AIR
9. ORCL
10. SPCX

Go back to FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Amgen Inc (NASDAQ: AMGN) Delayed: 423.64 +5.51 (1.32%)
Previous Close $418.13    52 Week High $176.85 
Open $414.37    52 Week Low $133.64 
Day High $424.57    P/E 63.80 
Day Low $414.11    EPS $6.64 
Volume 3,737,933